wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q26829152-F6379672-B95F-4310-BEAC-5E4D46DA1034
Q26829152-F6379672-B95F-4310-BEAC-5E4D46DA1034
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26829152-F6379672-B95F-4310-BEAC-5E4D46DA1034
Emerging pharmacologic treatment options for fragile X syndrome
P2860
Q26829152-F6379672-B95F-4310-BEAC-5E4D46DA1034
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26829152-F6379672-B95F-4310-BEAC-5E4D46DA1034
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fa9673a6f1e91a6a617a959d9d7aadc59a4f41f9
P2860
Mechanism of action for NNZ-2566 anti-inflammatory effects following PBBI involves upregulation of immunomodulator ATF3.